PATIENTS UNDERGOING CORONARY-ARTERY BYPASS GRAFT-SURGERY ARE AT HIGH-RISK OF IMPAIRED GLUCOSE-TOLERANCE AND DIABETES-MELLITUS DURING THE FIRST POSTOPERATIVE YEAR

被引:22
作者
FARRER, M
FULCHER, G
ALBERS, CJ
NEIL, HAW
ADAMS, PC
ALBERTI, KGMM
机构
[1] UNIV NEWCASTLE UPON TYNE,NEW MED SCH,DEPT CARDIOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,NEW MED SCH,DEPT MED,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[3] UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,OXFORD,ENGLAND
[4] ROYAL N SHORE HOSP,ST LEONARDS,NSW 2065,AUSTRALIA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1995年 / 44卷 / 08期
基金
英国惠康基金;
关键词
D O I
10.1016/0026-0495(95)90099-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study demonstrates that patients who have undergone coronary artery bypass graft (CABG) surgery have a high prevalence of abnormal glucose tolerance 3 months and 1 year later. Although only 6% were known to have diabetes mellitus (DM) preoperatively, a further 4% were classified DM at two oral glucose tolerance tests (OGTTs) over the subsequent year and a further 18% were classified as having impaired glucose tolerance (IGT) at 12 months, Reproducibility of the 120-minute plasma glucose level in the 75-g OGTT was estimated from a repeat test performed within 10 days. The coefficient of variation (CV) of 120-minute glucose was between 14% and 18%. The observed changes in class of glucose tolerance observed at OGTTs repeated 6 and 12 months after surgery differed from the predicted changes based purely on the estimated variability of 120-minute glucose measurement. There was evidence of regression to the mean for the IGT group. However, there was also evidence of deteriorating glucose tolerance in some subjects. Between 4% and 9% of those with IGT 3 months after CABG surgery developed DM by 12 months, and 26 (13%) of those with initially normal glucose tolerance (NGT) developed IGT. Insulin and glucose responses in the OGTT and estimates of insulin resistance and B-cell function from fasting samples show that insulin resistance was the principal abnormality in IGT subjects, whereas in DM subjects, both insulin resistance and B-cell dysfunction contributed. Analysis of preoperative patient characteristics showed that the presence of either a systolic blood pressure of 140 mm Hg or body mass index (BMI) of more than 25 kg/m(2) identified 51% of the subjects who would at 1 year after surgery include all those who would be classified DM and 67% of those who would have IGT. Further analyses including insulin levels identified groups at particularly high risk of DM, but no combination of readily available preoperative measures identified all those destined to be classified IGT. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:1016 / 1027
页数:12
相关论文
共 58 条
  • [1] ABRAMS ME, 1969, BRIT MED J, V258, P599
  • [2] VARIATIONS IN APOLIPOPROTEINS-B AND A1 DURING COURSE OF MYOCARDIAL-INFARCTION
    AVOGARO, P
    BON, GB
    CAZZOLATO, G
    QUINCI, GB
    SANSON, A
    SPARLA, M
    ZAGATTI, GC
    CATURELLI, G
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1978, 8 (03) : 121 - 129
  • [3] RELATIONSHIPS BETWEEN INSULIN-SECRETION, INSULIN ACTION, AND FASTING PLASMA-GLUCOSE CONCENTRATION IN NONDIABETIC AND NONINSULIN-DEPENDENT DIABETIC SUBJECTS
    BOGARDUS, C
    LILLIOJA, S
    HOWARD, BV
    REAVEN, G
    MOTT, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) : 1238 - 1246
  • [4] LIPOPROTEIN COMPOSITION IN INDIVIDUALS WITH IMPAIRED GLUCOSE-TOLERANCE
    CAPALDO, B
    TUTINO, L
    PATTI, L
    VACCARO, O
    RIVELLESE, A
    RICCARDI, G
    [J]. DIABETES CARE, 1983, 6 (06) : 575 - 578
  • [5] Castillo CF, 1991, NEW ENGL J MED, V6, P382, DOI 10.1056/NEJM199108083250602
  • [6] RISK-FACTORS FOR NIDDM IN WHITE-POPULATION - PARIS PROSPECTIVE-STUDY
    CHARLES, MA
    FONTBONNE, A
    THIBULT, N
    WARNET, JM
    ROSSELIN, GE
    ESCHWEGE, E
    [J]. DIABETES, 1991, 40 (07) : 796 - 799
  • [7] CUNNINGHAM MJ, 1987, AM J CARDIOL, V57, P1393
  • [8] ASSOCIATION BETWEEN IMPAIRED GLUCOSE-TOLERANCE AND CIRCULATING CONCENTRATION OF LP(A) LIPOPROTEIN IN RELATION TO CORONARY HEART-DISEASE
    FARRER, M
    GAME, FL
    ALBERS, CJ
    NEIL, HAW
    WINOCOUR, PH
    LAKER, MF
    ADAMS, PC
    ALBERTI, KGMM
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6908) : 832 - 836
  • [9] FULLER JH, 1980, LANCET, V1, P1374
  • [10] REPRODUCIBILITY AND COMPARATIVE ANALYSIS OF REPEATED INTRAVENOUS AND ORAL GLUCOSE-TOLERANCE TESTS
    GANDA, OP
    DAY, JL
    SOELDNER, JS
    CONNON, JJ
    GLEASON, RE
    [J]. DIABETES, 1978, 27 (07) : 715 - 725